| HOME >> MEDICINE >> TECHNOLOGY |
$
35.3$
.3$
.39$
48.4$
5.5$
.53Adjustments:Acquisition and integration costs
3.51.20.041.70.50.02Field corrective action
2.50.90.03---Litigation charge
1.00.40.01---Vendor product recall
---(2.1)(0.8)(0.02)Adjusted Earnings
$
42.3$
3.8$
.47$
48.0$
5.2$
.53Reconciliation: Adjusted EBITDA(Dollars in millions) Quarter Ended December 31 20122011Adjusted income before income taxes
$
42.3$
48.0Add back:Other expense
1.81.2Depreciation and amortization
31.126.6Adjusted EBITDA
$
75.2$
75.8 Hill-Rom Holdings, Inc. and SubsidiariesCondensed Consolidated Balance Sheets(Dollars in millions)December 31, 2012September 30, 2012AssetsCurrent AssetsCash and cash equivalents
$
7.6$
84.3Trade accounts receivable, net of allowances
373.1392.6Inventories, net
122.7126.9Other current assets
79.078.0Total current assets
682.4681.8Property, plant and equipment, net
245.5250.1Goodwill
342.5335.2Other assets
344.6360.5Total Assets$
,615.0$
,627.6LiabilitiesCurrent LiabilitiesTrade accounts payable
$
78.2$
80.7Short-term borrowings
115.2115.2Other current liabilities
178.3182.2Total current liabilities
371.7378.1Long-term debt
234.6237.5Other long-term liabilities
187.8199.4Total Liabilities794.1815.0Shareholders' Equity820.9812.6Total Liabilities and Shareholders' Equity$
,615.0$
,627.6Hill-Rom Holdings, Inc. and SubsidiariesCondensed Consolidated Statements of Cash Flows(Dollars in millions) Quarterly Period
'/>"/>
| SOURCE Hill-Rom Holdings, Inc. Copyright©2012 PR Newswire. All rights reserved |